PROTAMINE SULFATE
HEPARIN TOXICITY
APP PHARMACEUTI
Indication
Heparin toxicity
Heparin toxicity is an adverse clinical state resulting from excessive anticoagulation due to heparin administration or overdose, primarily affecting the vascular and hematologic systems. Read more about Heparin toxicity
6 drugs 5 manufacturers
Drugs that treat it
Common Heparin toxicity therapies.
PROTAMINE SULFATE
HEPARIN ANTAGONISTS·HEPARIN TOXICITY
APP/NOVAPLUS
PROTAMINE SULFATE
HEPARIN ANTAGONISTS·HEPARIN TOXICITY
APP/FRESENIUS K
PROTAMINE (protamine sulfate)
HEPARIN ANTAGONISTS·HEPARIN TOXICITY
FRESENIUS KABI
PROTAMINE SULFATE
HEPARIN ANTAGONISTS·HEPARIN TOXICITY
FRESENIUS KABI
PROTAMINE SULFATE
HEPARIN ANTAGONISTS·HEPARIN TOXICITY
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Heparin toxicity preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHeparin toxicity is an adverse clinical state resulting from excessive anticoagulation due to heparin administration or overdose, primarily affecting the vascular and hematologic systems.
Pathophysiologically, supra-therapeutic circulating levels of heparin excessively potentiate antithrombin III, leading to profound inhibition of factor Xa and thrombin and resulting in impaired secondary hemostasis.
The condition is clinically defined by markedly prolonged coagulation parameters—such as the activated partial thromboplastin time or anti-factor Xa levels—and manifests predominantly as minor to life-threatening hemorrhage, including gastrointestinal, retroperitoneal, intracranial, or post-procedural bleeding.
- nih.gov
Heparin toxicity is an adverse clinical state resulting from excessive anticoagulation due to heparin administration or overdose, primarily affecting the vascular and hematologic systems Pathophysiologically, supra-therapeutic circulating levels of heparin excessively potentiate antithrombin III, leading to profound inhibition of factor Xa and thrombin and resulting in impaired secondary hemostasis The condition is clinically defined by markedly prolonged coagulation parameters—such as the activ...
- nih.gov
Heparin toxicity is an adverse clinical state resulting from excessive anticoagulation due to heparin administration or overdose, primarily affecting the vascular and hematologic systems Pathophysiologically, supra-therapeutic circulating levels of heparin excessively potentiate antithrombin III, leading to profound inhibition of factor Xa and thrombin and resulting in impaired secondary hemostasis The condition is clinically defined by markedly prolonged coagulation parameters—such as the activ...
- nih.gov
The condition is clinically defined by markedly prolonged coagulation parameters—such as the activated partial thromboplastin time or anti-factor Xa levels—and manifests predominantly as minor to life-threatening hemorrhage, including gastrointestinal, retroperitoneal, intracranial, or post-procedural bleeding
Personalize your experience
Follow Heparin toxicity and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.